Long-acting medicines for innovative vector control
View More
Unitaid-funded projects develop innovative medicines, diagnostic tools and public health techniques and link them quickly, and at affordable prices, to those most in need.
Our grant projects apply the best that science has to offer to the fight against HIV and co-infections, tuberculosis and malaria in lower-resource countries.
Grant focus
The IMPACT project will develop long-acting injectable ivermectin to fight malaria transmission
Grantees
MedinCell
Status
Current
Amount
US$ 6,358,125
Disease
Malaria
View More
Grant focus
To bring better pediatric medicines for drug-resistant TB
Grantees
Stellenbosch University (SU)
Status
Current
Amount
US$ 18,926,925
Disease
Tuberculosis
View More
Grant focus
To transform oral HIV treatment into a long-acting injectable
Grantees
University of Washington
Status
Current
Amount
US$ 6,962,027
Disease
HIV and Co-Infection
View More
Grant focus
Bringing secondary prevention of cervical cancer to scale in low- and middle-income countries
Grantees
Expertise France
Status
Current
Amount
US$ 24,322,600
Disease
HIV and Co-Infection
View More
Grant focus
To develop long-acting formulations of key medicines and create a market for them
Grantees
University of Liverpool
Status
Current
Amount
US$ 32,004,459
Disease
HIV and Co-Infection, Malaria, Tuberculosis
View More
Grant focus
To pilot targeted next-generation sequencing, an innovation that provides fast, accurate diagnosis of drug-resistant TB
Grantees
Foundation for Innovative New Diagnostics (FIND)
Status
Current
Amount
US$ 14,500,000
Disease
Tuberculosis
View More
Grant focus
To create affordable solutions for preventing cervical cancer
Grantees
Clinton Health Access Initiative (CHAI)
Status
Current
Amount
US$ 32,958,435
Disease
HIV and Co-Infection
View More
Grant focus
To harness mobile technology to help patients adhere to their TB medications
Grantees
KNCV Tuberculosis Foundation
Status
Current
Amount
US$ 13,998,007
Disease
Tuberculosis
View More